# IBTROZI

NDC: 84651-200
Generic name: taletrectinib
Labeler / Manufacturer: Nuvation Bio Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250611

FDA application: NDA219713

## Active ingredients

- TALETRECTINIB ADIPATE: 272 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84651-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84651-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=51ac8e52-3269-4102-8dc8-dba22d82128c